Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis

Date
2011-10-13
Authors
Matthews K.
Wilkinson K.A.
Kalsdorf B.
Roberts T.
Diacon A.
Walzl G.
Wolske J.
Ntsekhe M.
Syed F.
Russell J.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The inflammatory response to Mycobacterium tuberculosis (M.tb) at the site of disease is Th1 driven. Whether the Th17 cytokines, IL-17 and IL-22, contribute to this response in humans is unknown. We hypothesized that IL-17 and IL-22 contribute to the inflammatory response in pleural and pericardial disease sites of human tuberculosis (TB). We studied pleural and pericardial effusions, established TB disease sites, from HIV-uninfected TB patients. Levels of soluble cytokines were measured by ELISA and MMP-9 by luminex. Bronchoalveolar lavage or pericardial mycobacteria-specific T cell cytokine expression was analyzed by intracellular cytokine staining. IL-17 was not abundant in pleural or pericardial fluid. IL-17 expression by mycobacteria-specific disease site T cells was not detected in healthy, M.tb-infected persons, or patients with TB pericarditis. These data do not support a major role for IL-17 at established TB disease sites in humans. IL-22 was readily detected in fluid from both disease sites. These IL-22 levels exceeded matching peripheral blood levels. Further, IL-22 levels in pericardial fluid correlated positively with MMP-9, an enzyme known to degrade the pulmonary extracellular matrix. We propose that our findings support a role for IL-22 in TB-induced pathology or the resulting repair process. © 2011 Elsevier Ltd. All rights reserved.
Description
Keywords
Citation
Tuberculosis
http://www.scopus.com/inward/record.url?eid=2-s2.0-79960265824&partnerID=40&md5=754ec0e36470fffbf52150fbbc9c330d